Calliditas Therapeutics (CALT) announces full FDA approval of TARPEYO to reduce the loss of kidney function Dec 20, 2023 04:35PM
Calliditas Therapeutics (CALT) Reports Publication of Full Results From NefIgArd Phase 3 Trial Aug 18, 2023 05:42AM
Calliditas Therapeutics (CALT) Reports Publication of Results from NefIgArd Phase 3 Trial Aug 15, 2023 04:57AM
Calliditas Therapeutics (CALT) TARPEYO Granted FDA Approval Dec 15, 2021 05:05PM